Background: Nowadays, there has been an increase in the number of studies focused on the search for bioactive compounds produced by hydrolytic reactions from natural sources, such as the Quinoa grain, which represents an interesting agro-alimentary source that can have a beneficial influence on health, specifically antihypertensive potential. For this reason, the aim of the present study was to evaluate the antihypertensive activity of the protein hydrolysates obtained of Quinoa, the results of which are important at that time, to consider the incorporation of such peptides in the design of functional foods. Materials and Methods: Quinoa (Chenopodium quinoa Willd.) seeds were ground and the obtained flour was degreased and the protein isolate was obtained by isoelectric precipitation. The protein isolate was enzymatically hydrolyzed with Alcalase® and Flavourzyme® and the antihypertensive effect of peptides against angiotensin converting enzyme was evaluate using a mixture of 50 µL of sample, 50 µL of ACE working solution, 200 µL of substrate working solution and the fluorescence was determined with a microplate fluorometer following these characteristics: λ (excitation) = 355-375 nm; λ (emission) = 400-430 nm. Results: Peptides obtained using Alcalase® (protein content= 72.13%; DH= 31.22%) showed the highest inhibitory activity against the angiotensin converting enzyme (ACE), close to 88%. Conclusion: The Quinoa protein hydrolysates can be considered as a new agri-food source to be incorporated in the elaboration of functional foods with antihypertensive potential.
Introduction
Quinoa (Chenopodium quinoa Willd.) from the Chenopodiaceae family is a pseudocereal that has been cultivated for thousands of years in the andean region of South America (Jancurová et al., 2009; Galvez-Ranilla et al., 2009 ). This grain counts with an exceptional nutritional value and is considered one of the best vegetable protein sources, as its protein levels are higher than those present in cereals. Besides, it contains all essential amino acids and is gluten-free by nature (González-Martín et al., 2014; Vega- Gálvez et al., 2010) .
In recent years, there has been an increase in the number of studies focused on the search for bioactive compounds from natural sources that can be usable and incorporated as an alimentary substitute, as well as the elaboration of functional foods (Rastogi and Shukla, 2013) . A wide range of agro resources, provide a rich source of bioactive peptides after gastrointestinal digestion. It has been demonstrated that these peptides present biological activity, such as the inhibition of the activity of the angiotensin converting enzyme (ACE), the principal causing agent of the hypertension, which is one of the most widespread chronic diseases in developed countries (Matsui et al., 1993; Kim et al., 2001; Wu and Ding, 2001 ). For this reason, Quinoa grain represents an interesting agro-alimentary source that can be modified chemically to provide improvements in its biofunctional properties, specifically for the treatment of hypertension.
Therefore, considering the degree of hydrolysis influences the bio-and techno-functional properties of the peptides, the aim of the present study was to evaluate the antihypertensive activity (inhibition of the angiotensin I converting enzyme) of the protein hydrolysates obtained of Quinoa, the results of which are important at the time, to consider the incorporation of such peptides in the design of functional foods.
Materials and Methods
Quinoa (Chenopodium quinoa Willd.) seeds were obtained from Vizana Nutrition Company (Monclova, Coahuila, México). The seeds were ground and the obtained flour was degreased by extraction with hexane for 9 h in a Soxhlet extraction unit. The defatted meal (0.25% ± 0.03 crude fat, dry matter basis) was stored in hermetically sealed containers at 4°C until use.
Obtention and Enzymatic Hydrolysis of Protein Isolates
The protein isolate was prepared as previously described by Vioque et al. (1999) . It was produced by suspending 1000 mg of quinoa defatted meal in water (1:10, w/v) with Na 2 SO 3 (0.25 %, w/v) at pH 10.5. The suspension was stirred for 1 h at 25°C then centrifuged for 25 min at 8500 rpm at 4°C; the protein in the supernatant was precipitated at pH 4.5. The protein isolate was hydrolyzed with Alcalase® and Flavourzyme® under the following parameters: substrate concentration, 5%; enzyme/substrate ratio, 0.3 AU g -1 for Alcalase® and 50 LAPU g -1 for Flavourzyme®; pH, 7 for Alcalase® and 8 for Flavourzyme®; temperature, 50 °C; hydrolysis time, 60 min. Degree of hydrolysis (DH) was calculated by determining free amino groups with 2,4,6-trinitrobenzenesulfonic acid (TNBS) following Adler-Nissen (1979). These enzymatic treatments will allow the obtaining of hypoallergenic hydrolysates.
Protein quantification
Total nitrogen was determined by combustion according to Dumas (1831) procedure and converted to crude protein considering that all the nitrogen is in raw using a conversion factor (AOAC, 1997).
SDS-PAGE of Quinoa Protein Fractions
Protein profile of Quinoa was carried out by SDS-PAGE with 5% stacking gel and 15% of separating gel and a standard protein marker (250-10 kDa) was used as molecular weight standard.
Determination of Molecular Weight Distribution of Bioactive Peptides
Molecular weights were analyzed by gel filtration chromatography using a molecular exclusion column monitoring at an absorbance of 280 nm.
ACE inhibitory activity
The inhibitory effect of peptides against angiotensin converting enzyme, were evaluated according to Sentandreu and Toldra (2006) . The angiotensin converting enzyme inhibition was calculated using the following equation: 
Statistical analysis
The collected data were analyzed using the statistical software IBM SPSS Statistics 20 ® . Statistical comparisons of mean values for each experiment were performed using a single ANOVA, followed by a Tukey test (P < 0.05).
Results and Discussion
The hydrolysates obtained from Chenopodium quinoa Willd. showed a 72.13±0.44% protein content, with a degree of hydrolysis of 31.22%, and the electrophoresis patterns are shown in Figure 1 . The chromatogram showed three chromatographic peaks with molecular weights of 4.25 kDa, 2.71 kDa and 1.11 kDa. These results anticipating the presence of peptides in which the inhibitory activity of the angiotensin converting enzyme can be evaluated (Figure 3) .
The influence exerted by the type of enzyme used during the hydrolysis on the inhibitory capacity of the angiotensin converting enzyme can be clearly seen. The action of Alcalase® and Flavourzyme® differed significantly (p<0.01) due to the different times of hydrolysis in the inhibition of ACE. The highest values are those shown the hydrolysates obtained with Alcalase®, which are around 80-90%, while the most deficient values are those exhibited with Flavourzyme®, ranging from 40-50%.
These results are very similar to those described by Aluko and Monu (2003) , who observed that the reduction of peptide size significantly increases the ability of the hydrolysate to inhibit ACE activity, reporting values ranging from 15 to 10% of residual activity using Alcalase®. This suggests that the low molecular weight peptides of Quinoa could be easily absorbed by the body, which results in a promising effect that helps to counteract health problems and the possibility of being incorporated as a food substitute in the formulation of functional foods. 
Conclusions
Quinoa bioactive peptides with molecular weights between 1 and 5 kDa obtained with Alcalase® showed a high potential to act as angiotensin converting enzyme inhibitors, besides to the advantage of its hypoallergenic character, which suggests that these peptides can be considered to be incorporated in the elaboration of functional foods.
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